Company / Interest Expense
Bausch Health Companies Inc. Interest Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.6B
FY2025
5-year range
$1.4B / $1.6B
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#4 of 44
Health Care
What the data says
Among 44 Health Care companies, Bausch Health Companies Inc. is in the bottom 9% for interest expense. Interest Expense returned to growth in FY2025 after 2 years of decline, reaching $1.6B.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of -1.0%. Top quartile in the Health Care sector.
Increased from $1.4B to $1.6B over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 44This company $1.6B Sector average $291.0M
▼
+451.2% above sector average
Key checks
Key Insights
- 5-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, interest expense increased 15.6% year-over-year.
- Ranks #4 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +15.6% |
| FY2024 | $1.4B | -2.7% |
| FY2023 | $1.4B | -7.0% |
| FY2022 | $1.5B | +7.6% |
| FY2021 | $1.4B | -15.4% |
| FY2020 | $1.7B | -8.4% |
| FY2019 | $1.8B | - |
| FY2018 | - | - |
| FY2017 | $1.8B | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026